Rectal prolapse in pediatrics.
Rectal prolapse in pediatrics has its highest incidence in infancy and is uncommonly seen in industrialized countries. The prolapse may involve only the mucosa (mucosal prolapse) or all layers of the rectum (complete prolapse or procidentia). It is usually detected by the child's parents and is brought urgently to medical attention; however, it is usually spontaneously reduced by the time they reach the practitioner's office. Rectal prolapse should be viewed as a symptom of an underlying condition rather than a discrete disease entity. Potential causes are increased intraabdominal pressure, diarrheal and neoplastic diseases, malnutrition, and conditions predisposing to pelvic floor weakness. Its strong association with cystic fibrosis makes the sweat test mandatory for infants and children with recurrent rectal prolapse. Of particular importance are three entities related to rectal prolapse that may easily escape diagnosis by practitioner: occult rectal prolapse, solitary ulcer of the rectum syndrome, and inflammatory cloacogenic polyps. The treatment of rectal prolapse is mainly conservative and is directed at the underlying conditions. Surgical intervention may be required for recurrent rectal prolapse refractory to conservative measures. The simplest, less invasive, yet highly effective approach, appears to be perirectal injection with a sclerosing agent. While the majority of children experience spontaneous resolution of the prolapse, the prognosis is worse when presentation occurs after the age of 4 years.
Siafakas
C
C
Department of Pediatrics, UT Southwestern Medical Center at Dallas, Texas.
Vottler
T P
TP
Andersen
J M
JM
D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis; D005260:Female; D006801:Humans; D007223:Infant; D007414:Intestinal Neoplasms / Q000150:complications / Q000175:diagnosis; D008297:Male; D009748:Nutrition Disorders / Q000150:complications / Q000175:diagnosis; D012005:Rectal Prolapse / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D012008:Recurrence; D012597:Sclerosing Solutions / Q000627:therapeutic use
D012597:Sclerosing Solutions